Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
Clinical trial NCT02206425 · COMPLETED
Trial details
- NCT number
- NCT02206425
- Sponsor
- Oncotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2018-01-19
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.